AMOYTOP Trademark

Trademark Overview


On Monday, December 20, 2021, a trademark application was filed for AMOYTOP with the United States Patent and Trademark Office. The USPTO has given the AMOYTOP trademark a serial number of 97180708. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2024. This trademark is owned by XIAMEN AMOYTOP BIOTECH CO., LTD.. The AMOYTOP trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; clinical medical reagents; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations, namely, antivirals; human growth hormone; medicinal preparations for t...
amoytop

General Information


Serial Number97180708
Word MarkAMOYTOP
Filing DateMonday, December 20, 2021
Status700 - REGISTERED
Status DateTuesday, April 2, 2024
Registration Number7347649
Registration DateTuesday, April 2, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; clinical medical reagents; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological preparations for the treatment of cancer; pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations, namely, antivirals; human growth hormone; medicinal preparations for the mouth and as sprays; nasal spray preparations; nutritional supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 27, 2021
Primary Code005
First Use Anywhere DateWednesday, May 31, 2023
First Use In Commerce DateWednesday, May 31, 2023

Trademark Owner History


Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, February 27, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 26, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 13, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 23, 2024USE AMENDMENT FILED
Tuesday, February 13, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 23, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023SOU EXTENSION 2 GRANTED
Thursday, June 1, 2023SOU EXTENSION 2 FILED
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU EXTENSION 1 GRANTED
Monday, December 12, 2022SOU EXTENSION 1 FILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 25, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 25, 2022NON-FINAL ACTION E-MAILED
Monday, April 25, 2022NON-FINAL ACTION WRITTEN
Friday, April 22, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, April 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 15, 2022ASSIGNED TO EXAMINER
Monday, December 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 23, 2021NEW APPLICATION ENTERED